Chemotherapy, bisphosphonates, now recommended for prostate cancer. Comment
Publication
, Journal Article
Moul, JW
Published in: Oncology Report
September 1, 2005
Duke Scholars
Published In
Oncology Report
EISSN
1548-5323
ISSN
1548-5323
Publication Date
September 1, 2005
Issue
FALL
Start / End Page
53 / 54
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Moul, J. W. (2005). Chemotherapy, bisphosphonates, now recommended for prostate cancer. Comment. Oncology Report, (FALL), 53–54.
Moul, J. W. “Chemotherapy, bisphosphonates, now recommended for prostate cancer. Comment.” Oncology Report, no. FALL (September 1, 2005): 53–54.
Moul JW. Chemotherapy, bisphosphonates, now recommended for prostate cancer. Comment. Oncology Report. 2005 Sep 1;(FALL):53–4.
Moul, J. W. “Chemotherapy, bisphosphonates, now recommended for prostate cancer. Comment.” Oncology Report, no. FALL, Sept. 2005, pp. 53–54.
Moul JW. Chemotherapy, bisphosphonates, now recommended for prostate cancer. Comment. Oncology Report. 2005 Sep 1;(FALL):53–54.
Published In
Oncology Report
EISSN
1548-5323
ISSN
1548-5323
Publication Date
September 1, 2005
Issue
FALL
Start / End Page
53 / 54
Related Subject Headings
- Oncology & Carcinogenesis